Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

0.8905 -0.0295 (-3.21%)
Streaming Delayed Price Updated: 1:46 PM EDT, Sep 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 93,565
Open 0.9100
Bid (Size) 0.8905 (1)
Ask (Size) 0.9000 (244)
Prev. Close 0.9200
Today's Range 0.8900 - 0.9200
52wk Range 0.8400 - 3.150
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
Via Benzinga

Performance

YTD
-57.19%
-57.19%
1 Month
-42.55%
-42.55%
3 Month
-27.60%
-27.60%
6 Month
-46.36%
-46.36%
1 Year
-67.14%
-67.14%

More News

Read More
Recap: BioLine Rx Q2 Earnings
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
US Markets Turn Higher As Dow Jumps Over 100 Points
Via Benzinga
EQUITY ALERT: Rosen Law Firm Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX
From Rosen Law Firm
Via Business Wire
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision
Via Benzinga
Recap: BioLine Rx Q1 Earnings
Via Benzinga
Recap: BioLine Rx Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why BioLineRx Shares Are Getting Obliterated Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BioLineRx Secures $40M In Debt Financing To Fund Commercialization Of Stem Cell Mobilization For Blood Cancer
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
BioLineRx Seeks FDA Nod For Stem Cell Mobilization Candidate
Via Benzinga
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
88 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Banned diamonds
Via Talk Markets
Monday Markets News
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.